1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Montserret, R. Penin, F. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic C3 H7 N O2 89.093 y ALANINE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US J.Virol. JOVIAM 0825 0022-538X 83 6257 6268 10.1128/JVI.02663-08 19357161 Identification of a Novel Determinant for Membrane Association in Hepatitis C Virus Nonstructural Protein 4B 2009 10.2210/pdb2jxf/pdb pdb_00002jxf 3601.116 Genome polyprotein Non-structural protein 4B, UNP residues 1751-1780 1 syn polymer NS4B(40-69) no no QTNWQKLEVFWAKHMWNFISGIQYLAGLST QTNWQKLEVFWAKHMWNFISGIQYLAGLST A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n database_2 pdbx_nmr_software pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Data collection Database references Derived calculations 1 0 2008-11-25 1 1 2011-07-13 1 2 2022-03-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_nmr_software.name BMRB Y PDBJ 2007-11-19 REL REL The peptide was synthesized by solid-phase synthesis; Free N and C termini sample structures with the least restraint violations 50 30 2D 1H-1H NOESY 2D 1H-1H TOCSY 2D 1H-13C HSQC 1 mM 50 % 50 % 0 6.5 ambient 298 K DGSA-distance geometry simulated annealing 1 lowest rmsd deviation from the ensemble 1mM NS4B(40-69); 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O 50% v/v Trifluoro Ethanol D2OH; 50% v/v H2O Varian collection VNMR Goddard chemical shift assignment Sparky Schwieters, Kuszewski, Tjandra and Clore structure solution X-PLOR NIH Schwieters, Kuszewski, Tjandra and Clore refinement X-PLOR NIH 500 Varian UNITYPLUS Varian UnityPlus GLN 1 n 1 GLN 1 A THR 2 n 2 THR 2 A ASN 3 n 3 ASN 3 A TRP 4 n 4 TRP 4 A GLN 5 n 5 GLN 5 A LYS 6 n 6 LYS 6 A LEU 7 n 7 LEU 7 A GLU 8 n 8 GLU 8 A VAL 9 n 9 VAL 9 A PHE 10 n 10 PHE 10 A TRP 11 n 11 TRP 11 A ALA 12 n 12 ALA 12 A LYS 13 n 13 LYS 13 A HIS 14 n 14 HIS 14 A MET 15 n 15 MET 15 A TRP 16 n 16 TRP 16 A ASN 17 n 17 ASN 17 A PHE 18 n 18 PHE 18 A ILE 19 n 19 ILE 19 A SER 20 n 20 SER 20 A GLY 21 n 21 GLY 21 A ILE 22 n 22 ILE 22 A GLN 23 n 23 GLN 23 A TYR 24 n 24 TYR 24 A LEU 25 n 25 LEU 25 A ALA 26 n 26 ALA 26 A GLY 27 n 27 GLY 27 A LEU 28 n 28 LEU 28 A SER 29 n 29 SER 29 A THR 30 n 30 THR 30 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 2 A A O H LEU TRP 7 11 1.59 1 A THR 2 -154.18 -119.59 2 A THR 2 -142.21 -105.05 2 A LEU 28 -101.57 51.34 3 A THR 2 -172.80 -131.67 3 A LEU 28 -169.67 63.48 4 A THR 2 -153.09 -52.09 4 A ASN 3 84.55 -45.82 5 A THR 2 -124.61 -119.92 5 A ASN 3 58.72 6.35 5 A LEU 28 -119.45 62.08 6 A THR 2 -92.17 -107.44 6 A ASN 3 66.86 -4.68 7 A THR 2 51.95 -109.49 7 A ASN 3 -156.37 -45.77 7 A LEU 28 -102.42 49.62 8 A THR 2 -139.79 -64.74 9 A ALA 26 -86.62 45.96 9 A LEU 28 55.28 17.82 9 A SER 29 173.74 152.20 10 A THR 2 66.47 -63.17 10 A ASN 3 81.73 -50.08 10 A SER 29 58.47 -160.90 11 A LEU 25 -120.45 -51.06 11 A SER 29 -161.69 -60.45 12 A THR 2 -155.86 -119.78 12 A SER 29 61.58 168.83 13 A THR 2 -158.89 -116.51 13 A ALA 26 -78.97 44.66 14 A THR 2 -144.18 -108.97 15 A THR 2 -109.26 -121.97 16 A THR 2 -143.62 -100.71 16 A SER 29 -80.59 -86.82 17 A ASN 3 77.79 -52.62 17 A SER 29 68.33 -64.29 18 A THR 2 -141.92 -117.74 18 A LEU 28 -103.95 48.95 19 A SER 29 60.91 -160.76 20 A LEU 28 -101.71 49.55 21 A LEU 28 -116.54 59.32 22 A THR 2 -101.69 -89.57 22 A LEU 28 -98.53 45.54 23 A THR 2 55.71 -98.85 23 A SER 29 59.06 -165.15 24 A THR 2 -162.39 -119.82 25 A ALA 26 -82.59 42.37 26 A THR 2 -161.10 -115.47 26 A GLN 23 -92.71 44.98 26 A TYR 24 -153.19 -54.94 27 A ALA 26 -79.62 46.59 27 A SER 29 -90.33 -156.25 28 A THR 2 -165.23 -120.55 29 A THR 2 -144.21 -115.20 30 A THR 2 -164.90 -116.47 30 A SER 29 62.85 -91.03 The solution structure of HCV NS4B(40-69) 1 N N A THR 2 A THR 2 HELX_P A LEU 28 A LEU 28 1 1 27 VIRAL PROTEIN, MEMBRANE PROTEIN membrane associated segment, Acetylation, Apoptosis, ATP-binding, Capsid protein, Cytoplasm, Endoplasmic reticulum, Envelope protein, Fusion protein, Glycoprotein, Helicase, Host-virus interaction, Hydrolase, Interferon antiviral system evasion, Lipid droplet, Lipoprotein, Metal-binding, Mitochondrion, Multifunctional enzyme, Nucleotide-binding, Nucleotidyltransferase, Nucleus, Oncogene, Palmitate, Phosphoprotein, Protease, Ribonucleoprotein, RNA replication, RNA-binding, RNA-directed RNA polymerase, Secreted, Serine protease, SH3-binding, Thiol protease, Transcription, Transcription regulation, Transferase, Transmembrane, Ubl conjugation, Viral nucleoprotein, Virion, Zinc, VIRAL PROTEIN, MEMBRANE PROTEIN POLG_HCVH UNP 1 1751 P27958 QTNWQKLEVFWAKHMWNFISGIQYLAGLST 1751 1780 2JXF 1 30 P27958 A 1 1 30